Healy James Insider Trades

Insider Trading History

Track insider trading activity for Healy James. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$138k 16,000 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$18.9M 2,194,278 shares
$8.60
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$122k 14,222 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$94.7k 11,000 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$125k 14,545 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$68.9k 8,000 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$288k 33,450 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$113k 13,950 shares
$8.13
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$94.7k 11,000 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$216k 25,080 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $488k 56,683 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 33,450 shares
$4.51
$8.61
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $808k 21,850 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 21,850 shares
$10.95
$37.00
BioAge Labs
BioAge Labs BIOA
Director
Holding Value $353k 22,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.7k 22,000 shares
$4.44
$16.04
Natera
Natera NTRA
Director
Holding Value $9.8M 46,260 shares
Last Trade
Apr 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.8k 142 shares
$153.79
$211.85
Natera
Natera NTRA
Director
Holding Value $9.77M 46,118 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.2k 114 shares
$176.92
$211.85
Natera
Natera NTRA
Director
Holding Value $9.75M 46,004 shares
Last Trade
Oct 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18k 153 shares
$117.67
$211.85
Natera
Natera NTRA
Director
Holding Value $9.71M 45,851 shares
Last Trade
Jul 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2k 177 shares
$102.67
$211.85
Natera
Natera NTRA
Director
Holding Value $9.68M 45,674 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$321k 2,964 shares
$108.29
$211.85
Bolt Biotherapeutics
Bolt Biotherapeutics BOLT
Director
Holding Value $105k 22,000 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 22,000 shares
$0.77
$4.75
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $272k 31,603 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 14,545 shares
$12.01
$8.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up